We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$39.8M
2
AGN
Allergan plc
AGN
+$27.2M
3
BID
Sotheby's
BID
+$17.1M
4
VSM
Versum Materials, Inc.
VSM
+$16.5M
5
ARRY
Array Biopharma Inc
ARRY
+$15.8M

Top Sells

Rank Stock Value
1
TVPT
Travelport Worldwide Limited
TVPT
+$27.8M
2
ULTI
Ultimate Software Group Inc
ULTI
+$19M
3
CNC icon
Centene
CNC
+$15M
4
LXFT
Luxoft Holding, Inc.
LXFT
+$14.7M
5
NAVG
Navigators Group Inc
NAVG
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENT
1576
CALL
DELISTED
Intersect ENT, Inc
XENT
$2K ﹤0.01%
+100
New +$2.7K
FPRX
1577
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2K ﹤0.01%
+400
New +$3.82K
UROV
1578
DELISTED
Urovant Sciences Ltd.
UROV
$2K ﹤0.01%
300
+107
+55% +$878
PRGX
1579
DELISTED
PRGX Global, Inc.
PRGX
$2K ﹤0.01%
+300
New +$2.16K
GSB
1580
DELISTED
GlobalSCAPE, Inc.
GSB
$2K ﹤0.01%
+200
New +$1.7K
FENC icon
1581
Fennec Pharmaceuticals
FENC
$377M
$1K ﹤0.01%
302
-13
-4% -$55
IOVA icon
1582
Iovance Biotherapeutics
IOVA
$2.77B
$1K ﹤0.01%
+60
New +$904
JNUG icon
1583
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$461M
$1K ﹤0.01%
+2
New +$843
ACH
1584
Accendra Health
ACH
$224M
$1K ﹤0.01%
242
-10
-4% -$34
ALIM
1585
DELISTED
Alimera Sciences
ALIM
$1K ﹤0.01%
68
-2
-3% -$28
LTHM
1586
DELISTED
Livent Corporation
LTHM
$1K ﹤0.01%
213
-11,550
-98% -$104K
IAA
1587
DELISTED
IAA, Inc. Common Stock
IAA
$1K ﹤0.01%
+19
New +$737
TYME
1588
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$1K ﹤0.01%
720
-162
-18% -$227
DZSI
1589
DELISTED
DZS Inc. Common Stock
DZSI
$1K ﹤0.01%
+100
New +$1.19K
STML
1590
DELISTED
Stemline Therapeutics, Inc.
STML
$1K ﹤0.01%
+61
New +$882
NTGN
1591
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$1K ﹤0.01%
133
-9
-6% -$50
ARQL
1592
CALL
DELISTED
Arqule Inc
ARQL
$1K ﹤0.01%
+100
New +$696
AA icon
1593
Alcoa
AA
$12.5B
– –
-5,988
Closed -$169K
A icon
1594
Agilent Technologies
A
$39.9B
– –
-252
Closed -$20K
ABBV icon
1595
AbbVie
ABBV
$431B
– –
-26,783
Closed -$2.11M
ABEO icon
1596
Abeona Therapeutics
ABEO
$393M
$0 ﹤0.01%
2
-3
-60% -$503
ACIW icon
1597
ACI Worldwide
ACIW
$5.61B
– –
-241
Closed -$8K
ACLS icon
1598
Axcelis
ACLS
$4.2B
– –
-637
Closed -$13K
ACRE
1599
Ares Commercial Real Estate
ACRE
$261M
– –
-548
Closed -$8K
ADBE icon
1600
PUT
Adobe
ADBE
$103B
– –
-4,500
Closed -$1.2M
62 63
64
65 66

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.